0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Dornase Aerosol Effect on Sputum Viscosity in Cases Of Cystic Fibrosis

Jack Lieberman, MD
JAMA. 1968;205(5):312-313. doi:10.1001/jama.1968.03140310070022.
Text Size: A A A
Published online

To the Editor:—  Deoxyribonucleic acid is not normally present in mucoid respiratory secretions but is a product of pulmonary inflammatory cellular debris.1,2 The DNA in mucopurulent secretions seems to contribute to the chronicity of respiratory disease by increasing the viscosity of such secretions. A therapeutic attack upon the DNA content of purulent respiratory secretions would therefore appear to be worthwhile in an attempt to reduce morbidity from respiratory infection and to enhance the effectiveness of antibiotics.3Pancreatic dornase is a commercially available enzyme preparation which liquifies purulent sputum in vitro.4,5 The reduction in viscosity occurs rapidly due to depolymerization of DNA5 and the induction of intrinsic proteolysis.6-8 Dornase aerosols have also been found to be useful in the evacuation of viscous mucopurulent secretions in bronchopulmonary disease.9-13 I recently described a method for measuring the viscosity of sputum with a coneplate viscosimeter, thereby providing a

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();